Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a neurovascular device company, for $550 million, according to a March 10 news release.
Scientia Vascular, based in Salt Lake City, has about 300 employees.
“Scientia’s portfolio of guidewires and catheters can be seamlessly integrated with Medtronic’s existing suite of neurovascular products,” the release said.
Medtronic said the acquisition is valued at $550 million and could include additional earn-out and milestone payments after the deal closes, which is expected in the first half of 2027.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
